Cargando…
Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
After intensive induction chemotherapy and complete remission achievement, patients with acute myeloid leukemia (AML) are candidates to receive either high-dose cytarabine-based regimens, or autologous (ASCT) or allogeneic (allo-SCT) hematopoietic stem cell transplantations as consolidation treatmen...
Autores principales: | Ferrara, Felicetto, Picardi, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016672/ https://www.ncbi.nlm.nih.gov/pubmed/31878297 http://dx.doi.org/10.3390/cancers12010059 |
Ejemplares similares
-
Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia
por: Ossenkoppele, Gert J, et al.
Publicado: (2013) -
History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia
por: Gorin, Norbert Claude
Publicado: (2021) -
Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2019) -
Impact of Covid-19 on the treatment of acute myeloid leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2020) -
Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
por: Ferrara, Felicetto
Publicado: (2020)